Abstract:Metastasis is the process through which cancer cells break away from a primary tumor, travel through the blood or lymph system, and form new tumors in distant tissues. One of the preferred sites for metastatic dissemination is the brain, affecting more than 20% of all cancer patients. This figure is increasing steadily due to improvements in treatments of primary tumors. Stereotactic radiosurgery (SRS) is one of the main treatment options for patients with a small or moderate number of brain metastases (BMs). A frequent adverse event of SRS is radiation necrosis (RN), an inflammatory condition caused by late normal tissue cell death. A major diagnostic problem is that RNs are difficult to distinguish from BM recurrences, due to their similarities on standard magnetic resonance images (MRIs). However, this distinction is key to choosing the best therapeutic approach since RNs resolve often without further interventions, while relapsing BMs may require open brain surgery. Recent research has shown that RNs have a faster growth dynamics than recurrent BMs, providing a way to differentiate the two entities, but no mechanistic explanation has been provided for those observations. In this study, computational frameworks were developed based on mathematical models of increasing complexity, providing mechanistic explanations for the differential growth dynamics of BMs relapse versus RN events and explaining the observed clinical phenomenology. Simulated tumor relapses were found to have growth exponents substantially smaller than the group in which there was inflammation due to damage induced by SRS to normal brain tissue adjacent to the BMs, thus leading to RN. ROC curves with the synthetic data had an optimal threshold that maximized the sensitivity and specificity values for a growth exponent β * = 1.05, very close to that observed in patient datasets. After treatment of brain metastases with radiation therapy, a fraction of patients experience tumor recurrences and others display radiation necrosis (RN). Clinical data shows that the growth of RNs is faster, as measured by the growth exponent, than that of recurrent brain metastases. This reflects the inflammatory nature of the former, and provides a method to distinguish RN in the clinics from relapsing metastatic lesions. A simple mathematical model for the inflammatory response and a more sophisticate discrete stochastic simulator with many biological details were been developed to provide a mechanistic explanation of the differential dynamics of tumor growth versus inflammatory responses after stereotactic radiation surgery of metastatic brain lesions.

Leveraging radiomics and machine learning to differentiate radiation necrosis from recurrence in patients with brain metastases

Differentiating Radiation Necrosis and Metastatic Progression in Brain Tumors Using Radiomics and Machine Learning

A Multidimensional Connectomics- and Radiomics-Based Advanced Machine-Learning Framework to Distinguish Radiation Necrosis from True Progression in Brain Metastases

Risk Classification of Brain Metastases via Radiomics, Delta-Radiomics and Machine Learning

Potential of radiomics analysis and machine learning for predicting brain metastasis in newly diagnosed lung cancer patients

Prediction of treatment response in patients with brain metastasis receiving stereotactic radiosurgery based on pre-treatment multimodal MRI radiomics and clinical risk factors: A machine learning model

A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images

Radiomics as an emerging tool in the management of brain metastases

154 Elucidating the Immune Landscape of Radiation Necrosis Through Single Cell Analysis of Recurrent Brain Lesions in Patients After Stereotactic Radio Surgery

Radiation necrosis after radiation therapy treatment of brain metastases: A computational approach

MRI-Based Machine Learning for Prediction of Clinical Outcomes in Primary Central Nervous System Lymphoma

Radiomics and Machine Learning in Brain Tumors and Their Habitat: A Systematic Review

Deep Learning Methodology for Differentiating Glioma Recurrence From Radiation Necrosis Using Multimodal Magnetic Resonance Imaging: Algorithm Development and Validation

Distinguishing recurrence from radiation-induced lung injury at the time of RECIST progressive disease on post-SABR CT scans using radiomics

Machine Learning and Radiomics of Bone Scintigraphy: Their Role in Predicting Recurrence of Localized or Locally Advanced Prostate Cancer

Machine learning based differentiation of glioblastoma from brain metastasis using MRI derived radiomics

Predicting local control of brain metastases after stereotactic radiotherapy with clinical, radiomics and deep learning features

Machine Learning in Lung Cancer Radiomics

Nimg-63. Leveraging Llms For Accurate Differentiation Of Radiation Necrosis And Tumor Progression In Brain Mri Reports: A Study On Automated Scoring And Clinical Implications

Radiomic-Based Prediction of Lesion-Specific Systemic Treatment Response in Metastatic Disease